Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 544
Aptamer sequence: GGGUUGGGAAGAAACUGUGGCACUUCGGUGCCAGCAACCC
Target unique ID: 5957
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_521 40-1 Molecule Adenosine-5'-triphosphate 700 nM 300 mM NaCl, 20 mM Tris (pH 7.6), 5 mM MgCl2 7687750
Structure information of aptamer
Aptamer Sequence: GGGUUGGGAAGAAACUGUGGCACUUCGGUGCCAGCAACCC
The optimal secondary structure in dot-bracket notation: ((((((...........((((((....)))))).))))))
The centroid secondary structure in dot-bracket notation: ((((((...........((((((....)))))).))))))
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_521 Description 40-1
Aptamer chemistry RNA Length 40 nt
GC content 60.0% Molecular weight 12,928.74 Da
Molarity of 1 μg/μl solution 77.35 μM Number of G-quadruplexes 2
G-Score 17 Function Targeted binding
Sequence GGGUUGGGAAGAAACUGUGGCACUUCGGUGCCAGCAACCC
Applications Binding to ATP
Target information
Type Detail Type Detail
PubChem ID 5957 Molecular name Adenosine-5-triphosphate
Molecular formula C10H16N5O13P3 Molecular weight 507.18
IUPAC name [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate InChIKey ZKHQWZAMYRWXGA-KQYNXXCUSA-N
LogP -1.629 Topological polar surface area 279.13
Hydrogen bond acceptor 14 Hydrogen bond donor 7

Synonym(s):
Adenosine triphosphate; 56-65-5; Adenosine 5'-triphosphate; ATP; Triphosphaden; adenosine-5'-triphosphate; Myotriphos; Striadyne; Triadenyl; Adephos; Atriphos; Atipi; Adenosine 5'-(tetrahydrogen triphosphate); Glucobasin; Adetol; Adynol; 5'-Atp; Triphosaden; Adenylpyrophosphoric acid; Triphosphoric acid adenosine ester; ATP (nucleotide); Adenosine 5'-triphosphoric acid; Cardenosine; Fosfobion; Adenosintriphosphorsaeure; adenosine-triphosphate; Ado-5'-P-P-P; Ara-ATP; H4atp; UNII-8L70Q75FXE; 9-beta-D-Arabinofuranosyladenine 5'-triphosphate; CHEBI:15422; adenylpyrophosphate; Adenosine, 5'-(tetrahydrogen triphosphate); adenosine 5' triphosphate; 3-Methylbenzo[d]thiazol-3-iuM chloride; CHEMBL14249; 8L70Q75FXE; 11016-17-4; adenosine-5'-triphosphoric acid; [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate; 119439-06-4; NCGC00163309-01; ((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate; 126339-06-8; 126827-79-0; Phosphobion; C10H16N5O13P3; 51963-61-2; EINECS 200-283-2; MFCD00065467; 1kxp; 1mau; 1maw; 1vjc; 1vjd; 1xsc; 1yid; 2cbz; 2fgh; Adenylpyrophosphorate; Adenosine triphosphat-; Triphosadenine (DCF); 1gz3; 1gz4; 1r0x; 1y8p; BDBM2; 3h-adenosine triphosphate; Adenosine 5 inverted exclamation mark -triphosphate; DSSTox_CID_2559; 5'-Adenyldiphosphoric acid; bmse000006; bmse000854; bmse000993; Epitope ID:135612; Adenosine 5'-triphosphorate; SCHEMBL8979; DSSTox_RID_76629; DSSTox_GSID_22559; GTPL1713; DTXSID6022559; 1b38; 1b39; 1m83; 1r10; 1t44; Bio1_000406; Bio1_000895; Bio1_001384; ACT02649; AMY22292; HY-B2176; ZINC4261765; Tox21_112044; BDBM50366480; s5260; AKOS022179934; CS-7674; DB00171; CAS-56-65-5; Adenosine 5'-triphosphate; Triphosphaden; [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate; 5'-(tetrahydrogen triphosphate) Adenosine; AC-32151; Adenosine-5'-(tetrahydrogen triphosphate); AS-19204; DB-022415; X5319; C00002; D08646; D70159; Q80863; 065A467; A831137; W-105506; A9788C43-4BC5-46E2-8560-41C5FA7D3AA3; 9H-purin-6-amine, 9-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]; ({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid; [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl (hydroxy-phosphonooxyphosphoryl) hydrogen phosphate; [(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl (hydroxy-phosphonooxyphosphoryl) hydrogen phosphate;((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate; [[[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxyphosphonic acid; 9H-Purin-6-amine, 9-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-.beta.-D-ribofuranosyl]-

Activity data

No relevant experimental diagram

Interaction ID 544
Target type Molecule
Target unique ID 5957
Activity 700 nM
Binding Conditions/Buffer

300 mM NaCl, 20 mM Tris (pH 7.6), 5 mM MgCl2

Assay

N/A

PubMed ID 7687750
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_599 RNA GUCUCUGUGUGCGCCAGAGAACACUGGGGCAGAUAUGGGCCAGCACAGAAUGAGGCCC 56.90%
Apta_599 RNA GUCUCUGUGUGCGCCAGAGAACACUGGGGCAGAUAUGGGCCAGCACAGAAUGAGGCCC 56.90%
Apta_2 RNA GGGCUUCUCUGGUUAGACCAGAUUUGAGCCUGGGAGCUCUCUGGCUAACUAGGGAACCC 55.93%
Apta_365 RNA GGACCUAUGCAGUAGCCAGUGUGGACUGGGCUGCCCCCCC 55.00%
Apta_703 RNA GGGCGGAUGAGACGCUUGGCGUGUGCUGUGGAGAGUCAUCCG 54.76%
Apta_588 RNA CCGGUGCGCAUAACCACCUCAGUGCGAGCAAGGAA 52.50%
Apta_758 RNA GGCUUUCGGGCUUUCGGCAACAUCAGCCCCUCAGCC 52.50%
Apta_1166 RNA GAUGUAACUGAAUGAAAUGGUGAAGGACGGGUCCAGUAGGCUGC 52.27%
Apta_856 RNA UGGGCCGGAGGUUAGCUUGCCCAUGGCAAGCAGGGCGCCACGGACCCA 52.08%
Apta_594 RNA GGGCUAUUGCUGGAGGGGCGCCACAUGAAAGUGGUGGUUGGGUGCGGUCGGCGAUAGCUC 51.67%
Apta_381 RNA AUUCUGUUGGCGAACUGUACGCAAGUACUGGAUGACAGCCUAUCUAU 51.06%
Apta_131 RNA GGGAGGACGAUGCGGUCCUGUCGUCUGUUCGUCCCCAGACGACUCGCCCGA 50.98%
Apta_133 RNA GGGAGGACGAUGCGGUGAGUCGUUCCCUUCGUCCCCAGACGACUCGCCCGA 50.98%
Apta_135 RNA GGGAGGACGAUGCGGAUUCUGGUUACUGGCCGCCCCAGACGACUCGCCCGA 50.98%
Apta_315 RNA GGGAGGACGAUGCGGUCGUAUUAUCCGCUGCACGCCAGACGACUCGCCCGA 50.98%
Apta_129 RNA GGGAGGACGAUGCGGACACCGUUAAUCUGAGGCCCUGUCCUAUUCCUUCACGCCUCAGA 50.85%
Apta_304 RNA CGGCCGAUAGAAAGACUACUUGAGCCCUUAAAUGAGGUUAUGUGCGGCCG 50.00%
Apta_366 RNA GGUUAGAGGCGACGUCCCGGAAUCCGCGCCCAUUGCCCCC 50.00%
Apta_453 RNA GGGCUAGCUGAUCGUACCAGUAGCGUGGCCUGGGGGGCCUAGUCGUGCGAUACUAACAGCUAACACCC 50.00%
Apta_633 RNA GGCAUCGGAAAGUGGGUUGAUGUAAGUAACAGGCGAUGCC 50.00%